COVID-19 News & Resource Center
[vc_row][vc_column][vc_column_text]EPI Health has graciously supported the COVID-19 News and Resource Center.
COVID-19 DERM TOPICS
COVID-19 Peer-reviewed Articles
Safely Reopening Derm Practices Video Series
JDD COVID-19 Webinar Series
COVID-19: Urgent Medical and Aesthetic Issues for Dermatology
Streamed live on April 1st, 2020, and now available to watch on-demand, this webinar panel provi …
[vc_row][vc_column][vc_column_text]EPI Health has graciously supported the COVID-19 News and Resource Center.
COVID-19 DERM TOPICS
COVID-19 Peer-reviewed Articles
Safely Reopening Derm Practices Video Series
JDD COVID-19 Webinar Series
COVID-19: Urgent Medical and Aesthetic Issues for Dermatology
Streamed live on April 1st, 2020, and now available to watch on-demand, this webinar panel provi … 
CASE
A 47-year-old woman presented for Mohs Micrographic Surgery for a biopsy-proven basal cell carcinoma involving the right nasal ala. The patient had a history of basal cell nevus syndrome (BCNS) and previous history of multiple basal cell carcinomas.
On initial examination, the patient was noted to have a few scattered pearly molluscoid papules on the head and neck, which were suspicio … 
Dr. Jeffrey S. Dover, in partnership with the Journal of Drugs in Dermatology, invited a panel of dermatology Key Opinion Leaders to share their experience as they reopen their practices. If you missed the first video in the series, you can watch it here. We continue the series with Dr. Nazanin Saedi, Associate Professor and Director of Laser Surgery and Cosmetic Dermatology in the Department o … 
Frontal fibrosing alopecia (FFA) is a primary lymphocytic cicatricial alopecia that is currently regarded as a variant of lichen planopilaris. FFA has historically been considered rare in black patients, in whom traction alopecia, central centrifugal cicatricial alopecia, and androgenetic alopecia are frequently assumed to be more common. JDD author Kimberly Huerth, MD, ME describes a case of FFA … 
Acne vulgaris is one of the most common reasons for visiting the dermatologist. Topical retinoids are a mainstay of and considered first-line treatment, but patients often face issues with tolerability, which can impact adherence to therapy. We continue our series, Therapeutic Cheat Sheet, with a closer look at the recently FDA approved trifarotene.
[caption id="attachment_10430" align="alignle … 